Mode
Text Size
Log in / Sign up
N/A Completed N=45 Randomized Double-blind Supportive Care

Mobile Coping Skills Training to Improve Cardiorespiratory Failure Survivors' Psychological Distress

Cardiorespiratory Failure
Source: ClinicalTrials.gov NCT04329702 ↗
Enrolled (actual)
45
Serious AEs
0.0%
Results posted
Feb 2023
Primary outcomePrimary: Change in Hospital Anxiety and Depression Scale (HADS) Questionnaire — 11.7; 11.3; 12.1 units on a scale

Summary

This is a pilot randomized clinical trial involving adult survivors of cardiorespiratory failure treated in intensive care units (ICUs) that is designed to test the acceptability, feasibility, and clinical impact of a coping skills training intervention (Blueprint) delivered via a mobile app. This trial will allow us to determine if new changes to intervention delivery, inclusion criteria, and other factors are successful. It will also inform the development of a next-step efficacy focused trial.

Outcome Measures

OutcomeResultp-value
PRIMARY
Change in Hospital Anxiety and Depression Scale (HADS) Questionnaire
11.0; 11.4; 13.5
SECONDARY
Change in Hospital Anxiety and Depression Scale (HADS) Questionnaire
11.0; 11.4; 13.5
SECONDARY
Change in Post-Traumatic Stress Symptom Inventory (PTSS)
28.9; 29.4; 31.3
SECONDARY
Client Satisfaction Questionnaire (CSQ)
29; 29.5; 25
SECONDARY
Intervention Adherence
36.5; 34.1
SECONDARY
Change in Quality of Life Visual Analog Scale
61.4; 72.5; 67.1
SECONDARY
Patient Health Questionnaire 10-item Scale (PHQ-10)
7.9; 6.5; 5.7
SECONDARY
Distress Associated With Depression and Anxiety Symptom Frequency
SECONDARY
Distress Associated With PTSD Symptom Frequency

Eligibility Criteria

INCLUSION CRITERIA

  • Adult (age ≥18)
  • Managed in a hospital setting for ≥24 hours during the time inclusion criterion #3 is met.
  • Acute cardiorespiratory failure / insufficiency, defined as ≥1 of the following:
  • mechanical ventilation via endotracheal tube for ≥4 hours
  • non-invasive ventilation (CPAP, BiPAP) for ≥4 hours in a 24-hour period provided for acute respiratory failure
  • new use of supplemental oxygen ≥2 liters per minute (or increase in baseline continuous oxygen)
  • use of vasopressors for shock of any etiology
  • use of inotropes for shock of any etiology
  • use of pulmonary vasodilators
  • use of aortic balloon pump or cardiac assist device for cardiogenic shock
  • use of diuretic intravenous drip
  • Cognitive status intact
  • No history of pre-existing significant cognitive impairment (e.g., dementia) as per medical chart
  • Absence of current significant cognitive impairment (impairment defined as ≥3 errors on the Callahan cognitive status screen)
  • Decisional capacity present
  • Absence of severe and/or persistent mental illness
  • Treatment for severe and/or persistent mental illness (e.g., psychosis, bipolar affective disorder, schizoaffective disorder, schizoid personality disorder, schizophrenia [as per medical record], hospitalization for any psychiatric disorder) within the 6 months preceding the current hospital admission
  • No endorsement of active suicidality at time of admission or informed consent
  • No active substance abuse at a severity that impairs ability to participate
  • Functional English fluency

EXCLUSION CRITERIA (in hospital):

  • Complex medical care expected soon after discharge (e.g., planned surgeries, transplantation evaluation, extensive travel needs for follow up care, disruptive chemotherapy/radiation regimen)
  • Unable to complete study procedures as determined by staff
  • Lack of access to either reliable smartphone with cellular data plan or wifi

INCLUSION CRITERIA (post-discharge)

  • Elevated baseline (T1) psychological distress symptoms, defined as HADS total score of ≥8

EXCLUSION CRITERIA (post-discharge)

  • Failure to randomize within 2 months post-discharge.
  • Failure to access app within 1 month after randomization in the absence of other explanation (e.g., hospitalization).
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04329702). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search